Health Professional Information
Asthma & Allergy
Nasal Polyps | NASAL POLYPS |
|
|
|
Polyps occur in 36% of patients with aspirin intolerance and 7% of patients with asthma. They are more common in patients who are not allergic with an incidence of 13% in non-allergic asthma and 5% of atopic asthma. In patients with rhino-sinusitis 2% have polyps with 5% occurring in non-allergic rhinitis and 1.5% in allergic rhinitis. In childhood asthma/rhinitis there is very low incidence of 0.1%. There is an increased incidence of inflammatory polyps in patients with cystic fibrosis. Histopathology
Four histological types
Pathogenesis
Eosinophils and mast cellsLarge numbers of eosinophil and mast cells are found throughout the polyp. There is also increased numbers of Mast Cells in the adjacent inferior turbinate. These cells contribute to the increased levels of mediators which in turn gives rise to the chronic symptoms Early stages of polyp formation
Sinus imaging
Clinical relationship of nasal polyps to asthmaIn patients with polyps the incidence varies depending on the study. From as low as 4% of patients with polyps having asthma to as high as 40% with most studies showing approximately 33%. The estimates of aspirin intolerance in nasal polyps also vary from 4-26% Nasal polyps and IgE - polyps in allergic peopleAlthough Nasal polyps are more common in patients without allergy. If patients with nasal polyps are allergic then they are more likely to have recurrence of the polyps. Nasal polyps and aspirinThere are a number of studies showing that aspirin desensitisation in patients with aspirin sensitivity can cause regression of the polyps. Individuals with aspirin sensitivity should be referred to a specialist in allergy for assessment for desensitisation to aspirin. In patients with nasal polyps and aspirin intolerance there is an increased rate of recurrence and the interval between polypectomies is reduced. Individuals with aspirin sensitivity should be referred to a specialist in allergy for assessment for desensitisation to aspirin. Allergic fungal sinusitis/polyposis
There is an increased incidence of nasal polyps associated with allergic fungal sinusitis. Medical managementTopical nasal steroidsIn Double Blind Placebo Controlled Studies 400 - 800 mcg Budesonide over 8 weeks has shown efficacy. In a follow-up Open trial only 33% of patients needed surgery over the next 12 months. Systemic steroids
Short course steroids have shown equal effectiveness to polypectomy via snare. Leukotriene antagonistsA number of studies have shown that leukotriene anatagonists can reduce symptoms in patients with nasal polyps. Respiratory tract epithelium lines the sinuses and this consists of psuedostratified ciliated columnar epithelium with goblet cells. Areas of metaplastic squamous cell epithelium can occur on the polyp surface. © ASCIA 2010 The Australasian Society of Clinical Immunology and Allergy (ASCIA) is the peak professional body of Clinical Immunologists and Allergists in Australia and New Zealand. Website: www.allergy.org.au Email: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it Postal address: PO Box 450 Balgowlah, NSW Australia 2093 DisclaimerASCIA Education Resources (AER) information is reviewed by ASCIA members and represents the available published literature at the time of review. Information contained in this document is not intended to replace professional medical advice and any questions regarding a medical diagnosis or treatment should be directed to a medical practitioner. Content last updated January 2010 |
||
| Last Updated ( Wednesday, 27 January 2010 ) | ||
| < Prev | Next > |
|---|
ASCIA MENU
Ascia Education Resources
| Patient Support Information |
| About AER |
| Patient Information |
| Health Professional Information |




